Ceramide activates NFkappaB by inducing the processing of p105.
about
Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes.Noninvasive quantitative imaging of protein-protein interactions in living subjects.Reporter gene imaging of protein-protein interactions in living subjectsActivation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytesCeramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.A cell-biological model of p75NTR signaling.Transcriptional impact of dietary methionine restriction on systemic inflammation: relevance to biomarkers of metabolic disease during agingNew concepts in white adipose tissue physiologyp65/RelA modulates BECN1 transcription and autophagy.Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.Activation of the JAK/STAT pathway by ceramide in cultured human fibroblasts.Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice.Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.A novel role for sphingolipid intermediates in activation-induced cell death in T cells.Divergence in regulation of nitric-oxide synthase and its cofactor tetrahydrobiopterin by tumor necrosis factor-alpha. Ceramide potentiates nitric oxide synthesis without affecting GTP cyclohydrolase I activity.
P2860
Q30598957-7C068814-669B-4620-9CFB-2526E7571FBCQ34016495-916C2265-E34E-4FDE-81FE-CD2CB0A74A73Q34606422-3D5E5E24-D7AC-4A0A-A1C4-6337D255BC51Q35027646-723DDD96-F8A2-45FA-BA11-8370CFEB4C3FQ36560514-06204927-5683-44D5-8EE3-A72D8DA652C7Q36793166-94340307-B17A-4FB9-A7F8-FB71C9B5D933Q37228258-D9EC8126-0848-419C-8964-77D6CC5900F8Q38199982-382EE839-5B8E-491E-838D-0E4A88EEB69FQ39872195-43D7D277-C241-4339-98AE-A192EEDF0E3BQ40165254-2331E821-839A-4BFB-8D1F-E11314D9E80AQ40771844-5212EE92-68BD-413A-93ED-BBC738E83A8EQ40862150-E28BEF91-7C34-4F85-9E23-17B621395F85Q41809221-36021C5B-B494-4A90-8B9A-22DB3868122AQ43583320-F57C6DA2-5B80-464A-8A31-ADCE613166DDQ44407054-BF69E16A-02D3-42D9-9A1F-6B12A38BA3C4Q55475744-72E8D12D-A323-4D6E-8ED8-64C74AD4FCAD
P2860
Ceramide activates NFkappaB by inducing the processing of p105.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Ceramide activates NFkappaB by inducing the processing of p105.
@en
Ceramide activates NFkappaB by inducing the processing of p105.
@nl
type
label
Ceramide activates NFkappaB by inducing the processing of p105.
@en
Ceramide activates NFkappaB by inducing the processing of p105.
@nl
prefLabel
Ceramide activates NFkappaB by inducing the processing of p105.
@en
Ceramide activates NFkappaB by inducing the processing of p105.
@nl
P2860
P356
P1476
Ceramide activates NFkappaB by inducing the processing of p105.
@en
P2093
L A O'Neill
M P Boland
P2860
P304
15494-15500
P356
10.1074/JBC.273.25.15494
P407
P577
1998-06-01T00:00:00Z